Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20386909 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)(TERMINATED)
Condition: Cancer
Intervention: Drug: VX-680 (an Aurora Kinase Inhibitor)

Study has passed its completion date and status has not been verified in more than two years.